One of the mechanisms that contributes to chemotherapy resistance in ovarian cancer is through TUBB3, a class III β-Tubulin (Umezu et al., 2008; Aoki et al., 2009; Roque et al., 2013). The gene discussed is TUBB3; the disease is ovarian carcinoma.